Brendan Teehan

ACAD

Brendan Teehan serves as Chief Commercial Officer at ACADIA Pharmaceuticals Inc. (ACAD). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

17 trades

$1.20M

Net Position

Net Seller

$1.20M

Companies Traded

PCRX, ACAD

Active Period

Jan 2022 – Jan 2026

17 total trades

Most Recent

Sell PCRX

Jan 30, 2026 · $106.4K

Brendan Teehan's Insider Trading at ACADIA Pharmaceuticals Inc. (ACAD)

Buys

0 · $0.00

Sells

16 · $1.10M

Total Shares Bought

Total Shares Sold

57,086

ACAD Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 19, 2024	Sell	10,329	$16.81	$173.6K	62,105
Aug 20, 2024	Sell	9,534	$15.28	$145.7K	52,177
May 3, 2024	Sell	3,477	$16.94	$58.9K	42,133
Apr 9, 2024	Sell	2,568	$17.87	$45.9K	38,796
Mar 27, 2024	Sell	5,140	$17.90	$92.0K	36,340
Feb 27, 2024	Sell	624	$24.67	$15.4K	31,432
Jan 9, 2024	Sell	731	$29.96	$21.9K	30,949
Nov 21, 2023	Sell	4,960	$22.64	$112.3K	30,393
May 19, 2023	Sell	14,869	$22.50	$334.6K	24,356
May 2, 2023	Sell	548	$21.18	$11.6K	9,487
Apr 7, 2023	Sell	1,751	$18.16	$31.8K	8,468
Feb 27, 2023	Sell	461	$18.78	$8.7K	5,195
Jan 10, 2023	Sell	532	$17.13	$9.1K	4,549
May 3, 2022	Sell	552	$18.18	$10.0K	3,437
Feb 25, 2022	Sell	472	$23.80	$11.2K	2,422
Jan 10, 2022	Sell	538	$23.05	$12.4K	1,788